Biomarkers, TumorGenomicsImmunotherapy
Dr. Walter John Urba, MD, PhD
NPI1548253602
- Publications
- 61
- Clinical trials
- 10
- Industry payments
- $16,157
- State license
- 1
- Year NPI issued
- 2005
- Practice address
- 4805 NE Glisan St, Portland, OR 97213
- Practice phone
- Call (503) 215-5696
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Urba's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Walter John Urba is a medical oncologist in Portland, Oregon
Dr. Urba practices in Portland, Oregon.
Dr. Urba's NPI, 1548253602, was assigned on August 24, 2005. Dr. Urba holds Oregon license MD18449.
NPI and contact details
- NPI
- 1548253602NPI Registry (opens in a new tab)
- NPI enumeration date
- August 24, 2005
- NPI status
- Active
- Practice phone
- (503) 215-5696
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Walter John Urba's practice address is in Portland, Oregon
Dr. Urba's practice address in the NPI Registry is 4805 NE Glisan St, Portland, OR 97213, in Multnomah County. The practice phone is (503) 215-5696.
- NPI Registry address4805 NE Glisan St, Portland, OR 97213 · Multnomah CountyPhone(503) 215-5696
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Walter John Urba's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Urba practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Urba's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Urba practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Walter John Urba is one of 91 medical oncologists in Oregon
Medical oncology is Dr. Urba's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Urba is licensed in Oregon.
Specialties and state licenses
- Medical oncology, OregonPrimary
Medical oncologists near Dr. Urba
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Walter John Urba has 61 publications on record
Dmand AI links 61 papers to Dr. Urba, published from 2011 to 2024. 2017 was the busiest year, with 6. The most frequent topics are Immunotherapy, Melanoma and Receptors, OX40. Dr. Urba has published most often in J Immunother Cancer. Dr. Urba's most frequent co-authors are Brendan David Curti, MD, Rom Samuel Leidner, MD and Marka Rae Crittenden, MD, PhD.
Papers61
Years published2011 to 2024
Dr. Urba's papers by year, 2014 to 2024
Topics Dr. Urba writes about most
- Immunotherapy
- Melanoma
- Receptors, OX40
- T-Lymphocytes
- Antibodies, Monoclonal
- Lymphocyte Activation
- Lymphocytes, Tumor-Infiltrating
- Programmed Cell Death 1 Receptor
Dr. Urba's most frequent co-authors
- Brendan David Curti, MD22 shared papers
- Rom Samuel Leidner, MD9 shared papers
- Marka Rae Crittenden, MD, PhD8 shared papers
Recent publications by Dr. Urba
See who Dr. Urba researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Urba works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Walter John Urba has worked on 10 clinical trials
Dmand AI links Dr. Urba to 10 clinical trials, 5 of them phase 2 studies. 10 are still active or recruiting. Conditions studied include Squamous Cell Carcinoma of Head and Neck, Triple Negative Breast Neoplasms and Carcinoma, Squamous Cell. Providence Health & Services sponsors the most, 9.
Clinical trials with Dr. Urba by phase
- 3Phase 1: 3 trials
- 2Phase 1/2: 2 trials
- 5Phase 2: 5 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Urba's trials
- Squamous Cell Carcinoma of Head and Neck
- Triple Negative Breast Neoplasms
- Carcinoma, Squamous Cell
- Breast Neoplasms
- Breast Neoplasms, Male
Investigators on the most trials with Dr. Urba
- Todd Shane Crocenzi, MD9 shared trials
- Rui Li, MD, PhD9 shared trials
- John E. Godwin, MD7 shared trials
Recent clinical trials with Dr. Urba
Phase II Randomized Study of High Dose Interleukin-2 Versus Stereotactic Body Radiation (SBRT) and High Dose Interleukin-2 (IL-2) in Patients With Metastatic Melanoma (opens in a new tab)
Active, not recruitingPhase 2
MelanomaNevi and MelanomasHigh-dose IL-2
A Phase Ib Study to Assess the Safety, Tolerability and Immunologic Activity of Preoperative IRX 2 In Early Stage Breast Cancer (opens in a new tab)
Active, not recruitingPhase 1
Breast Neoplasms, MaleTriple Negative Breast NeoplasmsCyclophosphamideIndomethacinOmeprazole
A Phase II Study of Nivolumab Combined With Bicalutamide and Ipilimumab in Metastatic HER2-negative Breast Cancer (opens in a new tab)
Active, not recruitingPhase 2
Breast NeoplasmsBreast DiseasesBicalutamideIpilimumabNivolumab
A Pilot and Phase II Study to Assess the Safety, Tolerability and Efficacy of Pembrolizumab Plus Chemotherapy in Metastatic Triple Negative Breast Cancer Patients (opens in a new tab)
Active, not recruitingPhase 1/2
Triple Negative Breast NeoplasmsNeoplasm MetastasisPembrolizumabCapecitabinePaclitaxel
Phase II Study of TGFβ Type I Receptor Inhibitor LY2157299 With Neoadjuvant Chemoradiation in Patients With Locally Advanced Rectal Adenocarcinoma (opens in a new tab)
Active, not recruitingPhase 2
Rectal NeoplasmsRectal DiseasesLY2157299CapecitabineFluorouracil
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Walter John Urba received $16,157 in industry payments from 2016 to 2024
CMS Open Payments shows 64 general payments to Dr. Urba from 8 drug and device companies from 2016 to 2024. Travel and lodging make up the largest share, 85% of the total. Bristol-Myers Squibb Company paid the most, $14,746.
General payments to Dr. Urba by program year, 2016 to 2024
General payments to Dr. Urba by kind, 2016 to 2024
$16.2Kin total
- Travel and lodging$13,80485%
- Food and beverage$1,5309%
- Consulting fees$8005%
- Education$230%
Companies that paid Dr. Urba the most, 2016 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Walter John Urba's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Walter John Urba
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Walter John Urba's NPI number?
Dr. Walter John Urba's NPI number is 1548253602. It was assigned on August 24, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Walter John Urba?
Dr. Walter John Urba is a medical oncologist in Portland, Oregon. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Walter John Urba practice?
Dr. Urba practices at 4805 NE Glisan St, Portland, OR 97213.
What is Dr. Walter John Urba's office phone number?
The practice phone on file for Dr. Urba is (503) 215-5696.
What is Dr. Walter John Urba's medical license number?
Dr. Urba holds Oregon license MD18449.
Has Dr. Walter John Urba received payments from drug or device companies?
CMS Open Payments shows $16,157 in general payments to Dr. Urba from 8 companies from 2016 to 2024. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. Walter John Urba been practicing?
Dr. Urba's NPI was assigned in 2005.
Does Dr. Walter John Urba do research?
Dmand AI links 61 publications to Dr. Urba, published from 2011 to 2024. Dr. Urba has worked on 10 clinical trials.
Who does Dr. Walter John Urba publish with?
Dr. Urba's most frequent co-authors are Brendan David Curti, MD (22 shared papers), Rom Samuel Leidner, MD (9 shared papers) and Marka Rae Crittenden, MD, PhD (8 shared papers).
Selling to medical oncology practices?
See medical oncologists in Oregon by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card